Lotus Eye Hospital and Institute Limited has issued a notice for a postal ballot to seek shareholder approval for key director-related resolutions. The resolutions include approving the continuation of K.S. Ramalingam (DIN: 01016571) as a Non-Executive Director from June 1, 2025, until February 8, 2026, and his subsequent appointment as a Non-Executive Director for a fresh term starting February 9, 2026. Additionally, the company seeks approval for the appointment of Dr. S. Natesan (DIN: 09012904) as an Independent Director for a consecutive second term of five years, from January 3, 2026, to January 3, 2031. Dr. Ramalingam, aged 76, brings extensive experience in clinical nephrology and hospital administration, having previously served as Whole-Time Director and CEO. Dr. Natesan, aged 78, is a renowned orthopedician with over 50 years of experience in medicine and hospital administration. The e-voting period for the postal ballot will commence on December 19, 2025, at 9:00 a.m. IST and conclude on January 17, 2026, at 5:00 p.m. IST. The cut-off date for determining voting eligibility is December 16, 2025. The company is facilitating e-voting through CDSL and NSDL platforms.